-+ 0.00%
-+ 0.00%
-+ 0.00%

Q32 Bio prices USD 55 million private placement at USD 8 a share

PUBT·05/27/2026 12:02:18
Listen to the news
Q32 Bio prices USD 55 million private placement at USD 8 a share
  • Q32 Bio priced a private placement of common stock and pre-funded warrants with expected gross proceeds of about USD 55 million.
  • Deal includes 6,725,000 common shares at USD 8 per share, pre-funded warrants for 150,000 shares priced at USD 8.
  • Closing expected May 28, 2026, subject to customary conditions.
  • BVF Partners led the financing; RA Capital Management, OrbiMed, Atlas Venture participated.
  • Morgan Stanley served as lead placement agent; Oppenheimer also acted as placement agent.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Q32 Bio Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202605270800PR_NEWS_USPR_____NE68794) on May 27, 2026, and is solely responsible for the information contained therein.